UK medicines regulator needs more resources.Big money for biosimilars.Fixing liberalism.2024 scientific breakthroughs.The Economist: Best books of 2024.
June 2, 2026
- FDA Concerns About Cancer Risk Sink Fulcrum Therapeutics’ Sickle Cell Disease Drug
- Peterson Health Analytics Launches With Focus on Employer-Sponsored Healthcare
- Desde infecciones que supuran hasta cáncer sin tratar: detenidos por el ICE describen negligencia médica a lo largo de EE.UU.
- What Data Delays Are Costing Healthcare — And Its Patients
Headlines
